WELKINZA Trademark

Trademark Overview


On Wednesday, May 6, 2020, a trademark application was filed for WELKINZA with the United States Patent and Trademark Office. The USPTO has given the WELKINZA trademark a serial number of 88903727. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Tuesday, March 2, 2021. This trademark is owned by Amgen Inc.. The WELKINZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, immunological and inflammatory related diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
welkinza

General Information


Serial Number88903727
Word MarkWELKINZA
Filing DateWednesday, May 6, 2020
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateTuesday, March 2, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, immunological and inflammatory related diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, March 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Tuesday, March 2, 2021ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Tuesday, March 2, 2021ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, March 2, 2021OPPOSITION TERMINATED NO. 999999
Tuesday, March 2, 2021OPPOSITION DISMISSED NO. 999999
Monday, January 11, 2021OPPOSITION INSTITUTED NO. 999999
Thursday, August 6, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 29, 2020EXAMINER'S AMENDMENT ENTERED
Friday, May 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 29, 2020EXAMINERS AMENDMENT E-MAILED
Friday, May 29, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, May 25, 2020ASSIGNED TO EXAMINER
Tuesday, May 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 9, 2020NEW APPLICATION ENTERED IN TRAM